Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs

07-Dec-2009 - Chiltern International Limited announced the appointment of Dr.Sharon Mooreas Executive Vice President, Global Quality & Medical Affairs. Dr. Moore is based at Chiltern's Bristol, Tennessee, USA office. Dr. Moore is a physician with 15 years of industry experience. Prior to joining Chiltern, ...

Chiltern is expanding its portfolio of offerings by launching its new Peri-Approval services

13-Jul-2006 - Peri-Approval studies begin at regulatory filing or when pivotal trials are nearing completion and extend through approval, the launch period and the remaining development life cycle of a drug. The Chiltern Peri-Approval services will cover Phase IIIb studies as well as Phase IV type studies, ...

Chiltern International opens new office in Czech Republic

12-May-2006 - Chiltern International announced the opening of a new European office, located in Prague, Czech Republic. The office will be headed up by Richard Schultz. Richard was previously external contractor for the Czech State Faculty Hospital, prior to being director of operations for the CRO Inveresk ...

Latin America is set to gain more and more momentum as a possible destination for clinical trials

21-Dec-2005 - According to Dr Faiz Kermani of Chiltern International, Latin American countries have a number of key factors that will help put a spotlight on them as the global industry grows and the manufacturers search for new, better and more cost effective areas in which to conduct medical trials. "One of ...

Clinical Research a booming career - Are you ready for it?

From Dr. Dipti Sawant, PhD, Senior CRA, Chiltern International Private Limited, Mumbai 400 059, India

15-Jul-2005 - Clinical Research is about rules and regulations and when one is aware of these rules and regulations then this facilitates working in this field. Not only pharmacy graduates and graduates in biological sciences but also medical doctors interested in research are pursuing careers as Clinical ...

India for the future of clinical trials

12-Jul-2005 - India is rapidly developing into an important center for global clinical trials, but despite its growing popularity many companies remain unaware of how established the market now is. While they are positive concerning the possibilities of carrying out high quality research in India, they still ...

Shaking off Japan's R&D jitters

03-Feb-2005 - Despite a slowing in growth over recent years and some key issues, the Japanese pharmaceutical market continues to offer huge potential, according to Dr Faiz Kermani of leading independent clinical research organization, Chiltern International. The Japanese pharmaceutical market remains the ...

Vidal to head up Chiltern International's French operation

21-Jan-2005 - Leading independent Clinical research Organization Chiltern International has announced the promotion of Philippe Vidal to General Manager of Chiltern France. Chiltern is enjoying impressive growth in France and has even been consulted by a delegation from the French Economic Ministry as ...

South Korea poised to become a major pharmaceutical industry player?

15-Dec-2004 - Despite the ongoing risks and costs of drug development, as well as a continuing of a general 'low ebb' in the industry, new players are using partnering tactics to build a presence in the global pharmaceutical market, most notably South Korea. Like many other emerging pharmaceutical sectors in ...

Indian pharmaceutical industry goes from strength to strength

Indian government established tax concessions to promote innovative R&D

03-Dec-2004 - The Indian pharmaceutical industry is going from strength to strength in establishing itself across the world. That's the verdict of Chiltern International, a leading independent clinical research organisation which is carrying out a range of projects with international clients. "The Indian ...